ÂÜÀòÂÒÂ×

Meng Chen is the Head of Biometrics at AstraZeneca R&D in China, where they lead various functions including statistics and clinical data management to support development strategies in Oncology and BioPharma. Prior to this role, Meng demonstrated expertise as the Biometrics China Site Head at Roche, effectively integrating local capabilities with global strategies. They have extensive experience in drug development and statistical analysis, having held positions at Pfizer and Novartis earlier in their career. Meng earned a Ph.D. in Statistics from the University of Wisconsin-Madison and also holds a Master's in Statistics from The Ohio State University.